Themis Medicare's Stock Underperforms with 'Sell' Call and Consecutive Losses

Themis Medicare, a smallcap pharmaceutical company, has been in the news recently due to its stock performance. According to MarketsMOJO, the stock has been given a 'Sell' call, with a loss of -5.08% on the day of opening. This underperformance is -0.41% compared to the sector. The stock has been on a downward trend for the past three days, with a consecutive fall of -6.68% during this period. Today, the stock opened with a gap down of -5.08% and touched an intraday low of Rs 203.3 (-5.77%). In terms of moving averages, the stock is currently higher than its 100-day and 200-day moving averages, but lower than its 5-day, 20-day, and 50-day moving averages. In comparison to the Sensex, Themis Medicare's 1-day performance is -0.56%, while the Sensex's performance is also -0.56%. Over the past month, Themis Medicare has seen a 0.19% increase, while the Sensex has seen a 1.63% increase. While there has been no mention of investor interest or expert opinions, it is clear that Themis Medicare's stock has been underperforming in the market. Investors may want to keep an eye on the stock's performance and consider their options carefully before making any decisions.